Skip to main content
WoMWeb of Medicine
SearchGraphHistory
Neurology›Condition·Updated Jun 27, 2026·v1

Spinal Cord Compression

Spinal cord compression is a neurologic emergency requiring urgent recognition, whole-spine MRI, and etiology-specific intervention. The most common cause is metastatic disease, followed by degenerative cervical myelopathy. Management includes immediate corticosteroids (dexamethasone) for neoplastic/inflammatory causes, surgical decompression within 24 hours for traumatic central cord syndrome, and radiation or separation surgery for metastatic disease. Prognosis depends on preoperative ambulatory status and timeliness of treatment. Prevention with bone-modifying agents (denosumab, zoledronic acid) reduces skeletal-related events in cancer patients.

High Evidence80 references·9,622 words·39 min read·v1
spinal cord compressionmyelopathymetastatic spinal cord compressiondegenerative cervical myelopathycauda equina syndromeneurologic emergencyBilsky gradedexamethasonesurgical decompression

Quick Reference

RxDrug of choiceDexamethasone 10 mg IV bolus, then 4 mg IV q6h for neoplastic/inflammatory spinal cord compression
AltAlternativesPrednisone 0.6-1 mg/kg/day PO for inflammatory causes (e.g., IgG4-related pachymeningitis); taper over 4-6 weeks
⊘AvoidMethylprednisolone for traumatic spinal cord injury (not recommended; increases infection risk without benefit)
DxTest of choiceWhole-spine MRI with contrast (T1, T2 fat-suppressed, post-contrast T1, STIR sequences)
ScKey scoreBilsky grade (0-3) on axial T2-weighted MRI: Grade 2 or higher with neurologic symptoms defines clinical MSCC and requires urgent intervention
→When to referAny patient with suspected spinal cord compression and neurologic deficit (motor weakness, sensory level, sphincter dysfunction) - refer to neurosurgery emergently
Spinal cord compression is a neurologic emergency; early MRI and intervention (corticosteroids, surgical decompression, or radiation) are critical to prevent permanent paralysis.
Spinal cord compression (SCC) is a neurologic emergency caused by mechanical compression of the spinal cord from an extrinsic or intrinsic mass, bony abnormality, or inflammatory process. The most common cause in adults is metastatic disease (breast, lung, prostate), while degenerative cervical myelopathy predominates in patients over 55. Without urgent intervention, irreversible paraplegia, quadriplegia, and loss of bowel/bladder function can occur within hours to days. Early recognition, whole-spine MRI, and etiology-specific treatment, including corticosteroids, surgical decompression, or radiation, are critical to preserve neurological function.

Overview and Recommendations

Background

  • •Spinal cord compression (SCC) is a clinical syndrome of neurologic dysfunction caused by mechanical compression of the spinal cord, defined by a three-axis taxonomy: anatomic level (cervical, thoracic, lumbar), compressive pathology (tumor, disc, abscess, fracture), and temporal course (acute, subacute, chronic). This framework directly determines urgency, imaging protocol, and treatment choice.
  • •Metastatic spinal cord compression (MSCC) is the most common cause in adults, accounting for the leading cancer-related neurologic morbidity. Primary tumors include breast, lung, and prostate cancer, with hematogenous seeding to the vertebral column and epidural space. Degenerative cervical myelopathy (DCM) is the most common cause in patients over 55 worldwide, resulting from disc-osteophyte complexes, ligamentum flavum hypertrophy, or ossification of the posterior longitudinal ligament.
  • •Other etiologies include infectious (epidural abscess, tuberculous spondylitis), traumatic (fracture-dislocation, central cord syndrome), inflammatory (rheumatoid atlantoaxial subluxation, IgG4-related pachymeningitis), vascular (spontaneous epidural hematoma), and congenital (basilar invagination, Chiari malformation). Each etiology has distinct risk factors and demographic patterns.
  • •Pathophysiology involves mechanical deformation of the cord, leading to direct axonal injury, microvascular compromise (anterior spinal artery territory most vulnerable), and a secondary neuroinflammatory cascade with microglial activation, cytokine release, and demyelination. The reversibility of injury depends on the duration and severity of compression.
  • •Untreated, the natural history is progressive: back pain precedes motor weakness by a median of 7 weeks in MSCC, but once weakness appears, progression to paraplegia can occur within days. In DCM, stepwise deterioration over months to years is typical, with acute worsening after minor trauma. Early intervention is the only modifiable factor to prevent permanent disability.

Evaluation

  • •Suspect spinal cord compression in any patient with acute or subacute back pain accompanied by motor weakness, sensory loss, gait disturbance, or sphincter dysfunction. The classic triad is localized back pain, a sensory level on the trunk, and early autonomic dysfunction (urinary retention, incontinence).
  • •Ask about onset and progression: acute (hours) suggests trauma, hemorrhage, or abscess; subacute (days to weeks) suggests metastatic tumor or infection; chronic (months to years) suggests degenerative stenosis or slow-growing tumor. Inquire about cancer history, recent infection, anticoagulant use, and risk factors for tuberculosis or autoimmune disease.
  • •Examine for motor weakness (proximal lower extremities first in thoracic lesions; upper extremities in cervical lesions), a discrete sensory level to pinprick, hyperreflexia and clonus below the lesion, Babinski sign, and decreased anal sphincter tone. Perform a rectal exam to assess voluntary contraction and bulbocavernosus reflex.
  • •Order urgent whole-spine MRI with contrast as the gold-standard test, must be obtained within 2-4 hours of clinical suspicion. Essential sequences: T1 without contrast (vertebral lesions), T2 with fat suppression (cord edema), post-contrast T1 (enhancing masses), and STIR (bone marrow edema). The entire spine must be imaged because skip lesions occur in up to 20% of metastatic cases.
  • •Use the Bilsky grading system on axial T2-weighted MRI to quantify severity: Grade 0 = bone-only disease; Grade 1a-1c = epidural impingement without cord compression; Grade 2 = cord compression with visible CSF; Grade 3 = cord compression without visible CSF. Grade 2 or higher with neurologic symptoms defines clinical MSCC and warrants immediate intervention.
  • •If MRI is contraindicated (e.g., non-MRI-conditional pacemaker), perform CT myelography (sensitivity ~85%). Do not delay imaging for laboratory results or specialist consultation.
  • •Obtain blood tests: CBC, ESR, CRP (elevated in infection), serum tumor markers (PSA, CA-125) if metastatic disease suspected, and autoimmune panel (ANA, anti-aquaporin-4, anti-MOG) if inflammatory myelitis is in the differential.
  • •Consider CSF analysis only when MRI is equivocal or infection/inflammation is suspected. Typical findings: pleocytosis, elevated protein (>45 mg/dL, >500 mg/dL suggests complete block), and hypoglycorrhachia in bacterial/fungal infection. Lumbar puncture is contraindicated if complete spinal block is present on MRI.
  • •Differentiate from mimics: transverse myelitis (longitudinally extensive T2 hyperintensity, patchy enhancement), spinal cord infarction (diffusion restriction, 'owl's eye' sign), peripheral neuropathy (no sensory level, normal MRI), and cauda equina syndrome (saddle anesthesia, areflexia, early sphincter loss).
  • •Electrodiagnostic studies (NCS/EMG) play a limited role in acute SCC but may help differentiate cord compression from peripheral neuropathy or radiculopathy in chronic cases. Somatosensory and motor evoked potentials are used intraoperatively, not diagnostically.

Management

  • •Administer corticosteroids immediately for suspected neoplastic or inflammatory spinal cord compression: dexamethasone 10 mg IV bolus, then 4 mg IV every 6 hours. This reduces vasogenic edema and provides a window for definitive therapy. Taper over 2-4 weeks after radiation or surgery.
  • •For traumatic spinal cord injury, high-dose methylprednisolone is no longer recommended, current guidelines advise against its use due to lack of benefit and increased risk of infection and gastrointestinal bleeding. Instead, maintain mean arterial pressure (MAP) ≥85 mmHg for the first 7 days using vasopressors (norepinephrine or phenylephrine) to optimize cord perfusion.
  • •Perform surgical decompression emergently for progressive neurologic deficit despite medical therapy, spinal instability, bony retropulsion, epidural abscess, or unknown primary tumor requiring tissue diagnosis. For acute traumatic central cord syndrome, decompression within 24 hours significantly improves motor recovery (meta-analysis: mean ASIA motor score improvement 8.2 points, 95% CI 3.1-13.3).
  • •For metastatic spinal cord compression, use the NOMS framework (Neurologic, Oncologic, Mechanical, Systemic) to guide treatment. Separation surgery (posterior decompression and fixation) followed by stereotactic body radiation therapy (SBRT) (24 Gy in 2 fractions) yields 12-month local failure rate of 9.4% and median overall survival 16.5 months.
  • •Radiation therapy alone is an option for radiosensitive tumors (lymphoma, myeloma) or poor surgical candidates. Short-course radiotherapy (4 Gy × 5) is non-inferior to longer courses (3 Gy × 10) for pain and distress relief (SCORE-2 trial). Dose-escalated regimens (15 × 2.633 Gy or 18 × 2.333 Gy) improve 1-year local progression-free survival (RAMSES-01 trial).
  • •For degenerative cervical myelopathy, surgical decompression is the mainstay. The RECEDE-Myelopathy trial is investigating ibudilast (60-100 mg daily) as an adjuvant to surgery, but results are pending. Dynamic MRI may reveal additional cord compression in up to 40% of patients with normal static studies.
  • •Initiate DVT prophylaxis with enoxaparin 40 mg SC once daily (or unfractionated heparin 5000 U SC three times daily if renal impairment) within 24-48 hours of admission, provided no active bleeding. Continue for at least 8 weeks in patients with persistent motor deficits. Add sequential compression devices until ambulatory.
  • •Manage neuropathic pain with gabapentin (start 300 mg PO TID, titrate to 1200 mg TID) or pregabalin (75-150 mg PO BID). For nociceptive pain, use NSAIDs (e.g., ibuprofen 600 mg PO q6h) with a proton pump inhibitor, or opioids (morphine 5-10 mg PO q4h PRN) for breakthrough episodes.
  • •Monitor respiratory function in cervical and high thoracic lesions: forced vital capacity (FVC) <20 mL/kg or <1 L signals impending respiratory failure, consider noninvasive ventilation or elective intubation. Use incentive spirometry and cough-assist devices for FVC >30 mL/kg.
  • •Prevent hospital-acquired complications: turn patient every 2 hours to avoid pressure injuries, remove indwelling catheter as soon as possible to reduce urinary tract infections, and initiate early mobilization and multidisciplinary rehabilitation (physical, occupational, speech therapy) within 24 hours of spinal stability.
  • •Refer to neurosurgery emergently for any patient with progressive neurologic deficit or Bilsky grade 2-3 compression. Discharge criteria: stable neurological examination, pain controlled on oral regimen, DVT prophylaxis in place, and a rehabilitation plan established.
  • •What NOT to do: Do not administer methylprednisolone for traumatic SCI. Do not delay MRI for laboratory results. Do not use NSAIDs in acute neoplastic compression (increase bleeding risk). Do not perform lumbar puncture in suspected cord compression (risk of herniation). Do not use non-dihydropyridine CCBs (diltiazem, verapamil) in acute management.

Board Review — High Yield

  • •Bilsky grade 2 or higher, cord compression with visible CSF effacement on axial T2 MRI; defines clinical MSCC and warrants urgent intervention.
  • •Dexamethasone 10 mg IV bolus, first-line for neoplastic/inflammatory cord compression; reduces vasogenic edema.
  • •Surgical decompression within 24 hours, improves motor recovery in traumatic central cord syndrome (Level 1a meta-analysis).
  • •Whole-spine MRI, gold standard; must include entire spine because skip lesions occur in 20% of metastatic cases.
  • •Preoperative ambulatory status, strongest predictor of functional outcome; 80-90% maintain ambulation if walking at presentation vs 30-40% if nonambulatory.
  • •Denosumab vs zoledronic acid, equally effective in reducing skeletal-related events (including SCC) in bone metastases (RR 0.85, 95% CI 0.68-1.06).
  • •Radium-223, reduces symptomatic skeletal events in castration-resistant prostate cancer with bone metastases (HR 0.66, NNT=12).
  • •Autonomic dysreflexia, hypertensive surge triggered by noxious stimuli below T6; treat by sitting patient upright, removing stimulus, and nifedipine 10 mg SL.
  • •FVC <20 mL/kg, signals impending respiratory failure in cervical/high thoracic lesions; consider elective intubation.
  • •Avoid methylprednisolone in traumatic SCI, current guidelines recommend against routine use due to lack of benefit and increased complications.

Deep Dive — Evidence Details

References

  1. [1]

    Yaman O, Zileli M, Avci İ et al.. “Basilar Invagination Diagnosis, Classification, and Radiology: WFNS Spine Committee Recommendations.” Spine (2025). PMID: 40331793 ↗

    L5SR_OBSCited in: Definition, Classification & Nomenclature
  2. [2]

    Jiang Z, Davies B, Zipser C et al.. “The value of Clinical signs in the diagnosis of Degenerative Cervical Myelopathy - A Systematic review and Meta-analysis.” Global spine journal (2023). PMID: 37903098 ↗

    L1SR_OBSCited in: Definition, Classification & Nomenclature
  3. [3]

    Wang J, Hai Y, Geng H et al.. “Risk stratification and clinical classification for postoperative neurological complications in post-tuberculosis kyphosis: a retrospective cohort study.” Journal of orthopaedic surgery and research (2025). PMID: 40691646 ↗

    L3COHORTCited in: Definition, Classification & Nomenclature, Epidemiology, Etiology & Risk Factors
  4. [4]

    Ridia KGM, Astawa P, Deslivia MF et al.. “A Systematic Review of Scoring System Based on Magnetic Resonance Imaging Parameters to Predict Outcome in Cervical Spinal Cord Injury.” Spine surgery and related research (2022). PMID: 36819628 ↗

    L5SR_OBSCited in: Definition, Classification & Nomenclature
  5. [5]

    Siempis T, Tsakiris C, Anastasia Z et al.. “Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis.” Rheumatology international (2022). PMID: 36378323 ↗

    L5SR_OBSCited in: Definition, Classification & Nomenclature
  6. [6]

    Ma Z, Ye Q, Ma X et al.. “Correlation of imaging characteristics of degenerative cervical myelopathy and the surgical approach with improvement for postoperative neck pain and neural function: a retrospective cohort study.” Quantitative imaging in medicine and surgery (2024). PMID: 38846315 ↗

    L3COHORTCited in: Definition, Classification & Nomenclature
  7. [7]

    Nakajima A, Hokari M, Yanagimura F et al.. “Long-Term Clinical Landscapes of Spinal Hypertrophic Pachymeningitis With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.” Neurology (2025). PMID: 40106756 ↗

    L3OTHERCited in: Pathophysiology & Mechanism (Neuroanatomic Localization), Clinical Presentation, Severity, Staging & Risk Stratification
  8. [8]

    Chabot PJ, Winans NJ, Fuller JS et al.. “Characterizing immune involvement in degenerative cervical myelopathy: a systematic review.” Journal of neurosurgery. Spine (2026). PMID: 42066366 ↗

    L5SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization), Severity, Staging & Risk Stratification, Prognosis & Natural History
  9. [9]

    Zhu J, Yu Y, Sun P et al.. “A case of IgG4-related spinal pachymeningitis with a large spinal cord cavity: case report and updated systematic review.” Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025). PMID: 40715640 ↗

    L4SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization)
  10. [10]

    Vavourakis M, Sakellariou E, Galanis A et al.. “Comprehensive Insights into Metastasis-Associated Spinal Cord Compression: Pathophysiology, Diagnosis, Treatment, and Prognosis: A State-of-the-Art Systematic Review.” Journal of clinical medicine (2024). PMID: 38930119 ↗

    L5SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization), Acute Management & Time-Critical Pathway
  11. [11]

    Stanners M, O'Riordan M, Theodosiou E et al.. “The mechanical properties of the spinal cord: a systematic review.” The spine journal : official journal of the North American Spine Society (2024). PMID: 38432298 ↗

    L5SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization)
  12. [12]

    Bin-Alamer O, Qedair J, Abou-Al-Shaar H et al.. “Surgical intervention ≤ 24 hours versus > 24 hours after injury for the management of acute traumatic central cord syndrome: a systematic review and meta-analysis.” Journal of neurosurgery. Spine (2024). PMID: 38335527 ↗

    L1SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization), Acute Management & Time-Critical Pathway
  13. [13]

    Weber M, Eysel P, Müller LP et al.. “Pediatric Cervical Spine Injuries: Lessons From a Rare Case of C5/C6 Facet Dislocation in an Adolescent With a Systematic Literature Review.” Pediatric emergency care (2025). PMID: 40190029 ↗

    L4SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization), Special Populations & Prevention
  14. [14]

    Kraus LM, Hostettler IC, Dieringer LM et al.. “Spinal Arachnoid Cysts and Their Intraoperative Differentiation From Spinal Cord Herniation: A Single-Center Cohort Study.” Operative neurosurgery (Hagerstown, Md.) (2025). PMID: 41439766 ↗

    L3COHORTCited in: Pathophysiology & Mechanism (Neuroanatomic Localization), Clinical Presentation, Complications
  15. [15]

    Diaz-Ordoñez L, Duque-Cordoba PA, Nieva-Posso DA et al.. “Phenotype-Genotype Correlation in Morquio A Syndrome: Protocol for a Meta-Analysis.” JMIR research protocols (2024). PMID: 39541578 ↗

    L5SR_OBSCited in: Pathophysiology & Mechanism (Neuroanatomic Localization)
  16. [16]

    Klepinowski T, Osiowski A, Grzyb W et al.. “Prevalence of os odontoideum: a systematic review, meta-analysis and meta-regression with implications for vertebral artery and osseous anomalies.” Neurosurgical review (2026). PMID: 41504791 ↗

    L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors
  17. [17]

    Oertel J, Uriza G, Radtke K et al.. “Syndromic Atlanto-axial Instability: WFNS Consensus on Screening and Surveillance, Sports Clearance, and Treatment Options.” Spine (2025). PMID: 39925311 ↗

    L5SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Special Populations & Prevention
  18. [18]

    Manz W, Khawaja S, Spencer C et al.. “De novo C5 palsy in the absence of prior surgery: a retrospective study of surgical management and outcomes in the United States.” Asian spine journal (2025). PMID: 41403203 ↗

    L3COHORTCited in: Epidemiology, Etiology & Risk Factors, Clinical Presentation, Severity, Staging & Risk Stratification
  19. [19]

    Luo M, He R, Tang Z et al.. “Surgical treatment of metastatic epidural spinal cord compression: a systematic review and meta-analysis.” Journal of orthopaedics (2025). PMID: 41246169 ↗

    L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors
  20. [20]

    Bachard A, Culié D, Villarmé A et al.. “Atypical laryngeal dyspnoea with life-threatening obstruction: a case report.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2025). PMID: 41430442 ↗

    L4CASE_REPORTCited in: Epidemiology, Etiology & Risk Factors
  21. [21]

    Deng F, Liu H. “Multilevel subdural and epidural hematoma after percutaneous kyphoplasty (PKP): a case report and literature review.” Frontiers in medicine (2025). PMID: 39902033 ↗

    L4CASE_REPORTCited in: Epidemiology, Etiology & Risk Factors, Special Populations & Prevention
  22. [22]

    Isaksson M, Bjerstedt N, Pietz G et al.. “Impact of complications on survival after surgery for metastatic spinal cord compression.” European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2026). PMID: 42223603 ↗

    L3OTHERCited in: Epidemiology, Etiology & Risk Factors
  23. [23]

    Chamberlain MC, Tredway TL, Born D et al.. “Teaching NeuroImages: sacral spine chloroma.” Neurology (2013). PMID: 24019392 ↗

    L4CASE_REPORTCited in: Clinical Presentation
  24. [24]

    Yayla A, Kaya B, Erşen Danyeli̇ A et al.. “Spinal angiolipoma: a systematic review and an illustrative case report of recurrent long-segment angiolipoma with mediastinal extension.” European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2026). PMID: 42171734 ↗

    L5SR_OBSCited in: Clinical Presentation, Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG), Prognosis & Natural History
  25. [25]

    Ibdah A, Hulliel A, Alafeef M et al.. “Conus medullaris epidermoid cyst: a rare cause of chronic Conus medullaris Syndrome: case report and systematic review.” European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2025). PMID: 41123613 ↗

    L4SR_OBSCited in: Clinical Presentation, Special Populations & Prevention
  26. [26]

    Pétriz L, Asensio E, Loureiro E et al.. “Role of Palliative Care in Onco-Hematology Retrospective Observational Cohort Study in Deceased In-Hospital Patients with SACT at the End of Life: Experience with Real-World Data from a Cancer Monographic Institution.” Cancers (2025). PMID: 41228260 ↗

    L4COHORTCited in: Clinical Presentation
  27. [27]

    Ramesh R, Osorio RC, Pekmezci M et al.. “Diagnosis and Management of Extranodal Rosai-Dorfman Disease Isolated to the Thoracic Spine: Systematic Review and Illustrative Case.” World neurosurgery (2026). PMID: 42214468 ↗

    L3SR_OBSCited in: Clinical Presentation, Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG), Prognosis & Natural History
  28. [28]

    Harland TA, Johnson D, Dalfino J et al.. “Intradural Fibrosis Following Percutaneous Spinal Cord Stimulator Placement: A Case Report.” Pain practice : the official journal of World Institute of Pain (2026). PMID: 42351324 ↗

    L4CASE_REPORTCited in: Clinical Presentation, Neurorehabilitation, Symptomatic & Supportive Care, Complications
  29. [29]

    Falade OO, Antonarakis ES, Kaul DR et al.. “Clinical problem-solving. Beware of first impressions.” The New England journal of medicine (2008). PMID: 18687644 ↗

    L4CASE_REPORTCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  30. [30]

    Xie N, Zhou Y. “Clinical Reasoning: Longitudinally Extensive Spinal Cord Lesions in a Middle-aged Man.” Neurology (2021). PMID: 34937777 ↗

    L4CASE_REPORTCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  31. [31]

    Cole JS, Patchell RA. “Metastatic epidural spinal cord compression.” The Lancet. Neurology (2008). PMID: 18420159 ↗

    L5REVIEW_NARRATIVECited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG), Prognosis & Natural History, Special Populations & Prevention
  32. [32]

    Kowalczyk I, Duggal N, Bartha R. “Proton magnetic resonance spectroscopy of the motor cortex in cervical myelopathy.” Brain : a journal of neurology (2011). PMID: 22180462 ↗

    L2OTHERCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  33. [33]

    Darabi H, Arora H, Shekouhi R et al.. “Degenerative cervical myelopathy diagnosis: applicability of artificial intelligence-enhanced modalities in a systematic review and meta-analysis.” European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2026). PMID: 41758363 ↗

    L1SR_OBSCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  34. [34]

    Watanabe S, Nakanishi K, Uchino K et al.. “Analysis of Skeletal-Related Events in a Liaison Treatment for Metastatic Spinal Tumors: A 10-Year Retrospective Study.” Spine surgery and related research (2025). PMID: 41988000 ↗

    L4COHORTCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG), Neurorehabilitation, Symptomatic & Supportive Care
  35. [35]

    Vithitsuwannakun A, Kamolvit W, Chongtrakool P et al.. “A rare and complex case report of superimposed clostridial spondylodiscitis and epidural abscess associated with spinal lymphoma of the thoracic spine.” BMC infectious diseases (2026). PMID: 42135664 ↗

    L4CASE_REPORTCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG), Complications, Special Populations & Prevention
  36. [36]

    Park CG, Kim HS, Kim SK. “Contralateral-Structure-Preserving Endoscopic Resection of Cervical Osteochondroma: A Technical Note.” Journal of clinical medicine (2026). PMID: 42355743 ↗

    L4OTHERCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  37. [37]

    Cho ST, Baek SH, Lee DH et al.. “Clinical Significance of Early MRI Assessment Following Separation Surgery for Metastatic Spinal Cord Compression.” The spine journal : official journal of the North American Spine Society (2026). PMID: 42331039 ↗

    L2OTHERCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  38. [38]

    M Arnest R, M Koch K, D Budde M et al.. “Machine learning-based MRI radiomics identifies patients with degenerative cervical myelopathy and predicts baseline function.” European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2026). PMID: 42217032 ↗

    L3OTHERCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  39. [39]

    Chen R, Liang M, Zhang Y et al.. “Performance comparison between a deep learning model and spine surgeons in detecting cervical spinal cord compression on radiographs.” Journal of neurosurgery. Spine (2026). PMID: 42172670 ↗

    L3OTHERCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  40. [40]

    Younus I, Jain H, Sarikonda A et al.. “Filling A Critical Gap in Metastatic Spine Care: A Novel Classification System for Neoplastic Cauda Equina Compression.” Spine (2026). PMID: 42102256 ↗

    L3OTHERCited in: Diagnosis & Workup (Neuroimaging, EEG, LP, NCS/EMG)
  41. [41]

    Saadoun S, Bell BA, Verkman AS et al.. “Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice.” Brain : a journal of neurology (2008). PMID: 18267965 ↗

    L2OTHERCited in: Severity, Staging & Risk Stratification, Prognosis & Natural History
  42. [42]

    Wong HCY, Choi JI, Marta GN et al.. “International Multidisciplinary Consensus Group for Malignant Spinal Cord Compression: recommendations for definitions, reporting items, and study endpoints for clinical trials and audits.” The Lancet. Oncology (2026). PMID: 41643700 ↗

    L1TRIAL_NONRANDOMCited in: Severity, Staging & Risk Stratification, Neurorehabilitation, Symptomatic & Supportive Care, Prognosis & Natural History
  43. [43]

    Donovan EK, Schnarr KL, Greenspoon JN et al.. “Stereotactic Body Radiation Therapy Boost Following Urgent 3D Conformal Radiation Therapy for Metastatic Epidural Spinal Cord Compression: A Phase 1 Feasibility Study.” International journal of radiation oncology, biology, physics (2025). PMID: 41448499 ↗

    L1TRIAL_NONRANDOMCited in: Severity, Staging & Risk Stratification, Neurorehabilitation, Symptomatic & Supportive Care
  44. [44]

    Baram A, El Choueiri J, Brembilla C et al.. “Dynamic MRI in Degenerative Cervical Myelopathy: A Systematic Review of Radiological Markers, Correlations, and Outcomes.” Journal of clinical medicine (2025). PMID: 41517513 ↗

    L2SR_OBSCited in: Severity, Staging & Risk Stratification
  45. [45]

    Zhang Y, Liu Y, Wang L et al.. “Preoperative dermatomal somatosensory evoked potentials in risk prediction of early postoperative neurological deterioration after thoracic spine surgery: a retrospective cohort study.” Journal of orthopaedic surgery and research (2026). PMID: 42216066 ↗

    L3COHORTCited in: Severity, Staging & Risk Stratification, Complications
  46. [46]

    Rotem-Kohavi N, Humphreys S, Noonan VK et al.. “Building a library of acute traumatic spinal cord injury images across Canada: a retrospective cohort study protocol.” BMJ open (2025). PMID: 41448680 ↗

    L4COHORTCited in: Severity, Staging & Risk Stratification, Acute Management & Time-Critical Pathway
  47. [47]

    Wang J, Xu F, Duan H et al.. “IgG4-related disease presenting with retroperitoneal fibrosis and hypertrophic spinal pachymeningitis: a rare case report and literature review.” Frontiers in immunology (2025). PMID: 40948786 ↗

    L4SR_OBSCited in: Acute Management & Time-Critical Pathway
  48. [48]

    Azad TD, Kartal A, Shafi M et al.. “Duraplasty in acute spinal cord injury: a systematic review.” European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2025). PMID: 40152995 ↗

    L2SR_OBSCited in: Acute Management & Time-Critical Pathway
  49. [49]

    Gendreau JL, Patel N, Brown NJ et al.. “Surgical Intervention for Primary B-cell Lymphoma of the Spine: A Systematic Review and Meta-analysis of Clinical Presentation, Treatment, Postoperative Outcomes, and Histologic Markers.” Clinical spine surgery (2023). PMID: 37684726 ↗

    L1SR_OBSCited in: Acute Management & Time-Critical Pathway
  50. [50]

    Mohamad J. “[Pathological spine fractures].” Radiologie (Heidelberg, Germany) (2025). PMID: 40956405 ↗

    L5GUIDELINECited in: Acute Management & Time-Critical Pathway
  51. [51]

    Slouma M, Rezgui S, Tbini H et al.. “Atlantoaxial Subluxation Related to Axial Spondylarthritis: A Case-Based Systematic Review.” Mediterranean journal of rheumatology (2024). PMID: 39886282 ↗

    L4SR_OBSCited in: Acute Management & Time-Critical Pathway
  52. [52]

    Wahlster S, Johnson NJ. “The Neurocritical Care Examination and Workup.” Continuum (Minneapolis, Minn.) (2024). PMID: 38830063 ↗

    L5CASE_REPORTCited in: Acute Management & Time-Critical Pathway
  53. [53]

    Hossain M, Hao S, Yeasin A et al.. “Development and validation of an MRI-Based nomogram for predicting neurological recovery after acute cervical spinal cord injury.” Spinal cord (2026). PMID: 42056250 ↗

    L3OTHERCited in: Acute Management & Time-Critical Pathway
  54. [54]

    Al Farii H, Frazer A, Farahdel L et al.. “Zoledronic Acid Versus Denosumab for Prevention of Spinal Cord Compression in Advanced Cancers With Spine Metastasis: A Meta-Analysis of Randomized Controlled Trials.” Global spine journal (2019). PMID: 32707021 ↗

    L1SR_MA_RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  55. [55]

    Fukuokaya W, Mori K, Urabe F et al.. “Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate.” JAMA network open (2024). PMID: 38488793 ↗

    L2RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  56. [56]

    Katakami N, Nishimura T, Hidaka Y et al.. “Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312).” Lung cancer (Amsterdam, Netherlands) (2023). PMID: 37307753 ↗

    L1RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  57. [57]

    Lou Y, Chen Y, Yuan Y et al.. “Study on the Correlation between Pain and Cytokine Expression in the Peripheral Blood of Patients with Bone Metastasis of Malignant Cancer Treated Using External Radiation Therapy.” Pain research & management (2022). PMID: 35845981 ↗

    L3RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  58. [58]

    Rades D, Šegedin B, Conde-Moreno AJ et al.. “Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression.” International journal of radiation oncology, biology, physics (2019). PMID: 31415797 ↗

    L1RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  59. [59]

    Glover M, Smerdon GR, Andreyev HJ et al.. “Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial.” The Lancet. Oncology (2015). PMID: 26703894 ↗

    L1RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  60. [60]

    Sartor O, Coleman R, Nilsson S et al.. “Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.” The Lancet. Oncology (2014). PMID: 24836273 ↗

    L1RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  61. [61]

    Smith MR, Halabi S, Ryan CJ et al.. “Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).” Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2014). PMID: 24590644 ↗

    L1RCTCited in: Long-term & Definitive Management (Evidence Ladder)
  62. [62]

    An N, Wang D, Zhang P et al.. “In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study.” Nature medicine (2026). PMID: 41882404 ↗

    L1TRIAL_NONRANDOMCited in: Long-term & Definitive Management (Evidence Ladder), Neurorehabilitation, Symptomatic & Supportive Care
  63. [63]

    Ghia AJ, Guha-Thakurta N, Munsell MF et al.. “Long-term Results From a Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Spinal Metastases With Epidural Extension.” International journal of radiation oncology, biology, physics (2025). PMID: 40614786 ↗

    L1TRIAL_NONRANDOMCited in: Long-term & Definitive Management (Evidence Ladder)
  64. [64]

    Davies B, Mowforth OD, Yordanov S et al.. “Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial-study protocol.” BMJ open (2023). PMID: 36882259 ↗

    L5TRIAL_NONRANDOMCited in: Long-term & Definitive Management (Evidence Ladder)
  65. [65]

    Ito K, Sugita S, Nakajima Y et al.. “Phase 2 Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord Compression.” International journal of radiation oncology, biology, physics (2021). PMID: 34715257 ↗

    L1TRIAL_NONRANDOMCited in: Long-term & Definitive Management (Evidence Ladder)
  66. [66]

    Nielsen AM, Laursen MRT, Rechner LA et al.. “Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial.” Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2025). PMID: 40324910 ↗

    L1RCTCited in: Neurorehabilitation, Symptomatic & Supportive Care
  67. [67]

    Gómez-Arévalo JA, Prieto-Garzón AC, García-Perdomo HA. “Therapeutic Opportunity Window for Surgical Management in Patients With Malignant Spinal Compression: Systematic Review And Meta-Analysis.” Clinical spine surgery (2025). PMID: 40844158 ↗

    L1SR_OBSCited in: Neurorehabilitation, Symptomatic & Supportive Care
  68. [68]

    Liu Z, Wang Y, Liu H et al.. “Anterior Transoral Odontoid Reduction With Clivocervical Fusion in Revision Surgery for Craniovertebral Junction Anomalies: A Case Report and Technical Note.” Orthopaedic surgery (2025). PMID: 41391843 ↗

    L4CASE_REPORTCited in: Neurorehabilitation, Symptomatic & Supportive Care
  69. [69]

    Shaik K, Rasmussen S, Rahme R et al.. “Bone modifying agents and multikinase inhibitors as treatments for chordoma: A TriNetX-based retrospective cohort study.” Clinical neurology and neurosurgery (2025). PMID: 41349423 ↗

    L3COHORTCited in: Complications
  70. [70]

    Liang H, Mao ZF, Huang JY et al.. “Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus.” Frontiers in endocrinology (2026). PMID: 42272806 ↗

    L4CASE_REPORTCited in: Complications
  71. [71]

    Chen C, Xu Y, Xu Y et al.. “Central Venous Catheter for Treating Pseudomeningocele Compressing the Spinal Cord After Thoracic Ossification Surgery: Case Series.” Orthopaedic surgery (2026). PMID: 41795939 ↗

    L4CASE_REPORTCited in: Complications
  72. [72]

    Fizazi K, Carducci M, Smith M et al.. “Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.” Lancet (London, England) (2011). PMID: 21353695 ↗

    L1RCTCited in: Prognosis & Natural History, Special Populations & Prevention
  73. [73]

    Duggal N, Rabin D, Bartha R et al.. “Brain reorganization in patients with spinal cord compression evaluated using fMRI.” Neurology (2010). PMID: 20200344 ↗

    L2OTHERCited in: Prognosis & Natural History
  74. [74]

    Czarnetzki C, Mollica C, Buri J et al.. “X-linked hypophosphatemia and spinal cord compression: a systematic review and illustrative case.” Acta neurochirurgica (2026). PMID: 42065796 ↗

    L1SR_OBSCited in: Prognosis & Natural History
  75. [75]

    Rades D, Lomidze D, Jankarashvili N et al.. “Higher Dose Irradiation for Malignant Spinal Cord Compression: Long-Term Results of the RAMSES-01 Trial.” Current oncology (Toronto, Ont.) (2026). PMID: 41892177 ↗

    L1TRIAL_NONRANDOMCited in: Prognosis & Natural History
  76. [76]

    Baydar AT, Taskala B, Topal B et al.. “Early Neurological Improvement and Ambulation Recovery After Delayed Surgery in Surgically Selected Nonambulatory Metastatic Epidural Spinal Cord Compression: A Retrospective Cohort Study.” Current oncology (Toronto, Ont.) (2026). PMID: 42187616 ↗

    L4COHORTCited in: Prognosis & Natural History
  77. [77]

    Agrawal V, Ali MF, Yasin F et al.. “A Systematic Review of Current Terminology for Conditions Preceding Degenerative Cervical Myelopathy: Evidence Synthesis to Inform an AO Spine Expert Opinion Statement.” Global spine journal (2025). PMID: 40304598 ↗

    L1SR_OBSCited in: Special Populations & Prevention
  78. [78]

    Vaishya S, Gaonkar V, Bedi MS et al.. “Clinical evaluation, diagnosis, and decision-making for metastatic spine tumors: WFNS spine committee recommendations.” Neurosurgical review (2024). PMID: 39673659 ↗

    L5SR_OBSCited in: Special Populations & Prevention
  79. [79]

    Asunis E, Cini C, Martikos K et al.. “Efficacy and Risks of Posterior Vertebral Column Resection in the Treatment of Severe Pediatric Spinal Deformities: A Case Series.” Journal of clinical medicine (2025). PMID: 39860381 ↗

    L4CASE_REPORTCited in: Special Populations & Prevention
  80. [80]

    Zhao Y, Yu B, Feng W et al.. “Initial Denosumab Versus Sequential Bisphosphonate-to-Denosumab for Prevention of Skeletal-Related Events in Breast Cancer with Bone Metastases: A Retrospective, Single-Center Study.” Cancers (2026). PMID: 42073549 ↗

    L3OTHERCited in: Special Populations & Prevention

Revision History

All updates applied to this page

Loading revisions…